Works by Guoping Sun


Results: 130
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000526638
    By:
    • Ren, Zhenggang;
    • Shao, Guoliang;
    • Shen, Jie;
    • Zhang, Li;
    • Zhu, Xu;
    • Fang, Weijia;
    • Sun, Guoping;
    • Bai, Yuxian;
    • Wu, Jianbing;
    • Liu, Lianxin;
    • Yuan, Yuan;
    • Zhang, Jingdong;
    • Li, Zhen;
    • Zhang, Ling;
    • Yin, Tao;
    • Wu, Jincai;
    • Hou, Xiaoli;
    • Wang, Qingyu;
    • Zhu, Jun;
    • Fan, Jia
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50